发明名称 NPP1 FUSION PROTEINS
摘要 The present invention provides a novel fusion polypeptide containing a catalytic portion of NPP1 fused to a targeting moiety, nucleic acids encoding the fusion polypeptide, a vector containing the nucleic acid integrated thereinto, a host cell transformed with the vector and pharmaceutical compositions comprising the fusion polypeptide.
申请公布号 US2014377859(A1) 申请公布日期 2014.12.25
申请号 US201414449364 申请日期 2014.08.01
申请人 Synageva BioPharma Corp. 发明人 Quinn Anthony;Harvey Alex J.;Xia Zhinan
分类号 C12N9/16 主分类号 C12N9/16
代理机构 代理人
主权项 1. A host cell comprising a recombinant nucleic acid that encodes a NPP1 fusion protein, wherein the NPP1 fusion protein comprises an NPP1 component, a targeting moiety, and an Fc region of an immunoglobulin, wherein a) the NPP1 component comprises the cystein-rich region and the C-termus catalytic domain of NPP1, b) the targeting moiety and the Fc region are each located C-terminally to the NPP1 component, and c) the NPP1 fusion protein has NPP1 enzymatic activity.
地址 Lexington MA US
您可能感兴趣的专利